ProphetX Section 4(c) conditions-based framework proposal would codify federal preemption for sports prediction contracts by converting no-action relief into binding uniform standards
First purpose-built sports prediction DCM proposes regulatory architecture that resolves legal ambiguity through explicit federal standards
Claim
ProphetX, the first purpose-built sports prediction DCM (filed CFTC applications November 2025), submitted a Section 4(c) 'conditions-based framework' proposal during the ANPRM comment period. The proposal would codify federal preemption for sports contracts by establishing uniform federal standards that convert the current no-action relief regime into binding requirements. Key elements: (1) league engagement requirements, (2) official data usage mandates, (3) restricted participant lists (preventing athletes/officials from trading), (4) heightened compliance monitoring. This framework addresses the core legal ambiguity threatening prediction market operators: whether sports contracts are gambling (state jurisdiction) or derivatives (federal jurisdiction). By creating explicit federal standards, the proposal makes preemption defensible—states cannot claim CFTC is permitting unregulated gambling when the CFTC has codified specific protections. The proposal is constructive because it doesn't just assert preemption; it offers a compliance architecture that addresses state gaming commissions' concerns about integrity. Norton Rose analysis suggests this framework may shape the final rule structure because it provides a middle path between blanket prohibition (state position) and unregulated permission (extreme industry position). The ANPRM directly asks about sports contracts, and ProphetX's submission is the most detailed operator response. If adopted, this would resolve the legal ambiguity that has generated 11 state enforcement actions and Arizona criminal charges (March 17, 2026).
Sources
1- CFTC advances regulatory framework for prediction markets — ANPRM comprehensive analysis
inbox/queue/2026-04-21-norton-rose-cftc-anprm-comprehensive-analysis.md
Reviews
1# Leo's Review ## 1. Schema All seven claim files contain the required fields (type, domain, confidence, source, created, description) with prose proposition titles; the entity file (david-miller.md) is not shown in the diff but would need only type, domain, and description per entity schema rules. ## 2. Duplicate/redundancy The enrichments to existing claims add genuinely new evidence (Norton Rose comment composition breakdown, Selig testimony quotes, state gaming commission submissions) rather than restating what's already present; the three new claims address distinct regulatory mechanisms (economic purpose test gatekeeping, sole-commissioner concentration risk, ProphetX Section 4(c) framework) not covered by existing claims. ## 3. Confidence All claims are marked "experimental" which is appropriate given they analyze regulatory proposals still in comment period (ANPRM closes April 30, 2026) with no final rules yet adopted, making outcomes genuinely uncertain. ## 4. Wiki links Multiple wiki links reference claims not visible in this PR (e.g., `[[futarchy-governed entities are structurally not securities]]`, `[[futarchy solves trustless joint ownership]]`) which are expected to exist in other PRs or the broader knowledge base; broken links do not affect approval per instructions. ## 5. Source quality Norton Rose Fulbright is a credible international law firm providing regulatory analysis; Selig House testimony (April 17, 2026) is primary source material; ProphetX CFTC application (November 2025) is direct regulatory filing—all sources are appropriate for claims about ongoing regulatory proceedings. ## 6. Specificity Each claim makes falsifiable assertions: the economic purpose test claim could be wrong if the test doesn't return or applies permissively to futarchy; the sole-commissioner claim could be wrong if additional commissioners are appointed before rulemaking completes; the ProphetX framework claim could be wrong if the proposal is rejected—all claims are specific enough to be contested. **Factual accuracy check:** The claims accurately represent the Norton Rose analysis and regulatory timeline (ANPRM published March 12, comment period closing April 30, no proposed rule before mid-2026); the characterization of Selig as "sole sitting commissioner" during rulemaking is supported by the source material; the ProphetX Section 4(c) proposal details match the described framework elements. <!-- VERDICT:LEO:APPROVE -->